GLP-1 Weight Loss: How Much Can You Really Lose?

Quick Answer

On semaglutide (Wegovy), the average weight loss is 14.9% of starting body weight over 68 weeks. On tirzepatide (Zepbound), it's up to 20.9% over 72 weeks. For someone starting at 250 lbs, that's 37 lbs on semaglutide and 52 lbs on tirzepatide. These are averages — individual results range from 5% to 35%+ body weight loss.

The Numbers You Actually Need

Let's skip the vague language and go straight to the clinical trial data.

STEP 1 Trial (Semaglutide 2.4 mg, 68 weeks):

Average weight loss: 15.3 kg (33.7 lbs) — 14.9% of starting weight
50% of patients lost ≥15% of body weight
Placebo group lost 2.6 kg on average (lifestyle intervention only)

SURMOUNT-1 Trial (Tirzepatide 15 mg, 72 weeks):

Average weight loss: 22.5 kg (49.6 lbs) — 20.9% of starting weight
57% of patients lost ≥20% of body weight
36% lost ≥25% of body weight

These results were achieved in adults with obesity (BMI ≥30 or ≥27 with comorbidities) without type 2 diabetes. People with type 2 diabetes typically lose slightly less weight on the same medications.

What 15% Weight Loss Actually Looks Like

Abstract percentages don't mean much without context. Here's what average GLP-1 weight loss looks like at different starting weights:

Starting Weight	Semaglutide (~15%)	Tirzepatide (~21%)
200 lbs	-30 lbs → 170 lbs	-42 lbs → 158 lbs
220 lbs	-33 lbs → 187 lbs	-46 lbs → 174 lbs
250 lbs	-37 lbs → 213 lbs	-52 lbs → 198 lbs
280 lbs	-42 lbs → 238 lbs	-59 lbs → 221 lbs
300 lbs	-45 lbs → 255 lbs	-63 lbs → 237 lbs

These are averages. Your result depends on several individual factors.

What Affects How Much You Lose

Dose: Higher doses produce more weight loss. Wegovy 2.4 mg outperforms Ozempic 1 mg for weight loss, even though both are semaglutide.

Duration: Weight loss continues for 12–18 months before plateauing. Most of the total weight loss occurs in the first year.

Starting weight: Heavier patients lose more pounds in absolute terms, though the percentage is similar across weight ranges.

Diet and activity: Clinical trials included basic lifestyle counseling. Patients who pair medication with dietary changes and exercise consistently lose more weight.

Diabetes status: People with type 2 diabetes lose approximately 2–5% less body weight on the same GLP-1 dose compared to non-diabetic patients. This may be related to beta-cell dysfunction and metabolic differences.

Genetics: Some individuals have naturally higher or lower GLP-1 receptor density or different responses to receptor activation. Approximately 10–15% of patients lose less than 5% of body weight and are considered non-responders.

The Timeline of GLP-1 Weight Loss

GLP-1 weight loss is not linear. The rate slows over time:

Months 1–3: 1–2 lbs per week average; dose is titrating upward
Months 3–6: 0.5–1 lb per week; appetite reduction is at peak
Months 6–12: 0.25–0.5 lb per week; approaching plateau
Months 12–18: Plateau for most patients; some continued loss

Maximum weight loss is typically reached at 12–18 months. Weight is then maintained at roughly that level with continued dosing.

Start Your GLP-1 Journey Today

Bottom Line

GLP-1 medications produce 15–21% average body weight loss over 12–18 months — the most effective weight loss results ever achieved with a medication. Your individual result will fall somewhere in a wide range, but the evidence is clear that meaningful weight loss is the norm, not the exception.